comparemela.com

Latest Breaking News On - Marc oliver grimm - Page 1 : comparemela.com

Subsequent Therapies After mHSPC Progression on Darolutamide Offer Similar Survival

Investigators report survival by post-progression subsequent therapies after darolutamide for metastatic prostate cancer (mHSPC).

United statesMarc oliver grimmJena university hospital inOliver grimmJena university hospital

Best Urologist in the World

<p

United statesSan diegoCzech republicLibor zamecnikMarc oliver grimmJens ottoManfred beerCaterina laniaJan hrbacekFrancesco montorsiLuis garcia aparicioMichal ogrodnikTorremade barreda josepPawel salwaStephen culpMartin kriegmair

Adaptive Nivolumab Plus Ipilimumab Improves Outcomes in mRCC

Nivolumab plus ipilimumab for mRCC improves clinical outcomes compared with nivolumab alone.

France generalUnited statesSan diegoLa jollaMarc oliver grimmPedroc barataRana mckayUniversity of californiaLeader of the genitourinary oncology disease teamJena university hospital of friedrich schillerBristol myers squibb gmbh coEuropean society for medical oncologyMoores cancer centerEuropean societyMedical oncologyOliver grimm

Adaptive Nivolumab Plus Ipilimumab Improves Outcomes in mRCC

Nivolumab plus ipilimumab for mRCC improves clinical outcomes compared with nivolumab alone.

France generalUnited statesSan diegoLa jollaMarc oliver grimmPedroc barataRana mckayUniversity of californiaLeader of the genitourinary oncology disease teamJena university hospital of friedrich schillerEuropean society for medical oncologyMoores cancer centerEuropean societyMedical oncologyOliver grimmJena university hospital

Fewer Complications With Robotic Nephrectomy in Complex Kidney Tumors

However, trial comparing robotic and open surgery was stopped early due to low enrollment

United statesComunidad autonoma de catalunaMarc oliver grimmAlberto bredaMike bassettEuropean association of urologyUniversity hospital in jenaUniversity hospitalEuropean association

vimarsana © 2020. All Rights Reserved.